Etanercept Biosimilar Safe and Effectively Treats RA - DocWire News

Etanercept Biosimilar Safe and Effectively Treats RA  DocWire News

The results of a recent trial found that patients with moderate-to-severe rheumatoid arthritis (RA) who switched from etanercept (ETN) to biosimilar sandoz.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases